The one-time award of $50,000 will allow research on molecular mechanisms controlling multi-cilia to continue.
A new review article in the journal Cancers explores epigenetic therapy.
BUSM biophysicists dissect the first step in reverse cholesterol transport.
The authors believe this is the first contemporary study to quantifying the magnitude of life expectancy loss at different age groups due to assault and suicide firearm mortality among black and white Americans.
Dr. Hamilton has received research support from Kowa Pharmaceuticals America to help to provide a clearer explanation of the differential risk and interference in glucose regulation and insulin sensitivity.
Identifying the risk factors for weight regain is an important first step in improving the long-term clinical outcomes of bariatric surgery.
New, More Accessible Staging System Developed to Predict Survival for Patients with Light Chain Amyloidosis
The test incorporates cardiac biomarkers to accurately identify the involvement of the heart in the disease.
Elevated Blood Pressure in People Under 40 Poses Hazard of Developing Cardiovascular Diseases Prematurely
In a JAMA editorial, Vasan Ramachandran, MD, states that understanding the basis of elevated BP in young adults is critical for preventing the condition.
BUSM, VA researchers have identified a gene that might influence which individuals are at greater risk to develop severe CTE.
On Friday Oct. 26, the Framingham Heart Study (FHS) invited all of its participants to a two-part, daylong celebration – an open house at its headquarters and a public celebration complete with refreshments and distinguished guest speakers.